Clare Blue

Senior CMC Translation Consultant

Clare has over 16 years CMC industry experience in the development and manufacture of gene therapy / biologics products, from pre-clinical to commercial. She had a lead role in defining the CMC, regulatory and analytical strategies of a start-up gene therapy company with success taking an ocular AAV product to pivotal / Phase 3 trials, together with extensive experience supporting the technical development of various clinical and pre-clinic products in the ocular and CNS space. She provides expert advice to external industry forums and advisory boards to facilitate the advancement of ATMPs.